FluoxetineLack of efficacy following off-label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1939卷 / 1期

关键词：

D O I：

10.1007/s40278-023-31627-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：219 / 219

相关论文

共 50 条

[31] Multiple drugsLack of efficacy following off-label use: case report
[J]. Reactions Weekly, 2022, 1930 (1) : 387 - 387
[32] Mifepristone/misoprostolLack of efficacy following off-label use: case report
[J]. Reactions Weekly, 2023, 1981 (1) : 245 - 245
[33] Various drugsLack of efficacy following an off-label use: case report
[J]. Reactions Weekly, 2021, 1863 (1) : 317 - 317
[34] Dexamethasone/favipiravirLack of efficacy following off-label use: case report
[J]. Reactions Weekly, 2023, 1938 (1) : 509 - 509
[35] Multiple drugsLack of efficacy following off-label use: case report
[J]. Reactions Weekly, 2023, 1969 (1) : 268 - 268
[36] Ciclesonide/favipiravirLack of efficacy following off-label use: case report
[J]. Reactions Weekly, 2023, 1975 (1) : 111 - 111
[37] Multiple drugsLack of efficacy following off-label use: case report
[J]. Reactions Weekly, 2022, 1912 (1) : 323 - 323
[38] Multiple drugsLack of efficacy following off-label use: case report
[J]. Reactions Weekly, 2022, 1932 (1) : 420 - 420
[39] Multiple drugsLack of efficacy following off-label use: case report
[J]. Reactions Weekly, 2025, 2045 (1) : 281 - 281
[40] Methylprednisolone/tocilizumabLack of efficacy following off-label use: case report
[J]. Reactions Weekly, 2022, 1922 (1) : 383 - 383

← 1 2 3 4 5 →